Alan M. Jacobson received his M.D. from the University of Chicago Medical School. He has been on the faculty of Harvard Medical School since 1973, and is now Emeritus Professor of Psychiatry. He started the Joslin Diabetes Center’s Behavioral Research and Clinical Mental Health Programs and later became Chief Medical Officer of the Joslin Clinic- a multi-specialty group practice.

In 2009 Dr Jacobson moved to Winthrop University Hospital, where he became Chief Research Officer and Director of its new Research Institute and Center for Diabetes Research. As CRO, he is charged with integrating research with Winthrop’s clinical and educational missions, centralizing research activities, developing effective strategies to maximize external funding and building research throughout the hospital. In this capacity, he will oversee the establishment of a strong diabetes-oriented research program.

He has served as the Principal Investigator for the Joslin Diabetes Center’s Diabetes Control and Complications Trial (DCCT)/ Epidemiology of Diabetes Control and Complications (EDIC) site and directs the behavioral science component of the DCCT/EDIC study. He has published over 150 papers and articles on topics related to his research and clinical activities. He has been funded continuously for the last 30 years by a series of grants from the National Institutes of Health, and is currently funded by three NIH grants.
Description of Research Interests/Activities
Dr. Jacobson’s investigations focus on the psychological aspects of diabetes. His studies have examined the impact of diabetes on the structure, chemistry and function of the central nervous system; the quality of life of patients and their families; the effects of psychological and social factors on the course and outcomes of diabetes; and the development of psychological and medical interventions to improve outcomes of diabetes.
He is currently studying:
• The long-term effects of type 1 diabetes on cognitive functioning and health-related quality of life as part of the long term follow-up of the DCCT cohort.
• The impart of T1DM on urologic complications
• The acute and chronic effects of T1DM and hyperglycemic and glutamate using MRI
• The impact of T2DM in humans on functional connectivity of the brain’s default network as a possible early biomarker for Alzheimer’s Disease
• Effects of insulin resistance on brain functioning and structure

Category: Nonprofits & Activism
Uploaded by: Diabetes Hands Foundation
Hosted: youtube